Skip to content
OpenCapital
Get started

MIRA Pharmaceuticals, Inc. MIRA Q1 2026 Annual earnings

Reported May 14, 2026 · Before market open

EPS-$0.03

Next report

Sep 2, 2026 (in a month)

Versus estimates

Revenue

Q4 2024$11.2M

Diluted EPS

Q1 2026-$0.03
Q4 2025-$0.15Miss by $0.11Q3 2025-$1.18In lineQ2 2025-$0.09Beat by $0.02Q1 2025-$0.11Beat by $0.04Q4 2024-$0.15Beat by $0.14

Ask the moment MIRA Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MIRA Pharmaceuticals, Inc. report Q1 2026 earnings?
MIRA Pharmaceuticals, Inc. (MIRA) reported Q1 2026 earnings on May 14, 2026 before market open.
What were MIRA Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
MIRA Pharmaceuticals, Inc. reported eps of $-0.03 for Q1 2026.
How did MIRA Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 72.7% from $-0.11.
Where can I find MIRA Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-022608) and the 10-K periodic report (0001493152-26-014001) directly on SEC EDGAR. The filing index links above go to sec.gov.